Onderneming Zhejiang Ausun Pharmaceutical Co., Ltd.
Aandelen
603229
CNE100002XK2
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,49 CNY | +0,87% | +9,84% | -20,59% |
Vakgebied
Aantal werknemers: 1 129
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular
25,0
%
| 34 | 5,9 % | 191 | 25,0 % | +468,48% |
Liver Diseases
23,6
%
| 157 | 27,6 % | 180 | 23,6 % | +14,85% |
Nervous System
16,1
%
| 90 | 15,9 % | 123 | 16,1 % | +36,08% |
Antibacterial
11,0
%
| 115 | 20,1 % | 84 | 11,0 % | -26,94% |
Gout
9,4
%
| 46 | 8,1 % | 72 | 9,4 % | +54,76% |
Other
7,2
%
| 55 | 9,7 % | 55 | 7,2 % | -0,45% |
Technical Services
4,2
%
| 33 | 5,7 % | 32 | 4,2 % | -2,62% |
Prostaglandin
2,5
%
| 14 | 2,5 % | 19 | 2,5 % | +35,50% |
Respiratory System
0,5
%
| 10 | 1,8 % | 4 | 0,5 % | -60,19% |
Anti-tumor
0,3
%
| 15 | 2,6 % | 3 | 0,3 % | -82,63% |
High-end Fluorine
0,3
%
| 1 | 0,2 % | 2 | 0,3 % | +137,25% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
International
57,3
%
| 306 | 53,7 % | 438 | 57,3 % | +43,36% |
China
42,7
%
| 264 | 46,3 % | 326 | 42,7 % | +23,59% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 15-12-14 |
Ding Min Zhu
DFI | Director of Finance/CFO | 57 | 02-11-21 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14-12-14 |
Tuan Tuan Wang
IRC | Investor Relations Contact | - | - |
Xiao Chen Ying
SEC | Corporate Secretary | 43 | 25-12-21 |
Yu Zhong
PRN | Corporate Officer/Principal | 62 | 15-07-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fei Chen
BRD | Director/Board Member | 44 | 08-01-15 |
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 15-12-14 |
Bing Liu
FOU | Founder | 55 | 14-12-14 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14-12-14 |
Shi Lan Zheng
BRD | Director/Board Member | 49 | 14-12-14 |
Yu Liu
BRD | Director/Board Member | 42 | 15-12-14 |
Fu Li Zhang
BRD | Director/Board Member | 56 | 13-12-17 |
He Min Zhu
BRD | Director/Board Member | 37 | 01-01-13 |
Ming Min Luo
BRD | Director/Board Member | 51 | 13-12-20 |
Guan Neng Yu
BRD | Director/Board Member | 37 | 01-01-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 593 069 389 | 237 411 769 ( 40,03 %) | 0 | 40,03 % |
Bedrijfsgegevens
Zhejiang Ausun Pharmaceutical Co., Ltd.
5 Donghai Fourth Avenue Linhai Park
317016, Taizhou
+
http://www.ausunpharm.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,59% | 859 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers 603229
- Onderneming Zhejiang Ausun Pharmaceutical Co., Ltd.